{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:56:55Z","timestamp":1769050615523,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.medcli.2017.07.023","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T16:52:04Z","timestamp":1507827124000},"page":"262-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Escherichia coli  y  Klebsiella pneumoniae  productores de betalactamasa de espectro extendido en infecciones de v\u00edas urinarias: evoluci\u00f3n de la resistencia antibi\u00f3tica y opciones terap\u00e9uticas"],"prefix":"10.1016","volume":"150","author":[{"given":"Gemma","family":"Jim\u00e9nez-Guerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Heras-Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda del Carmen","family":"B\u00e9jar Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Sorl\u00f3zano-Puerto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Navarro-Mar\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Guti\u00e9rrez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.medcli.2017.07.023_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0213-005X(15)30013-6","article-title":"[Microbiological diagnosis of urinary tract infections] Spanish","volume":"33","author":"De Toro-Peinado","year":"2015","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.medcli.2017.07.023_bib0060","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.eimc.2014.11.009","article-title":"Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology","volume":"33","author":"Rodriguez-Bano","year":"2015","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.medcli.2017.07.023_bib0065","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. Wayne, PA: Clinical and Laboratory Standards Institute; 2015."},{"key":"10.1016\/j.medcli.2017.07.023_bib0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1345\/aph.1Q473","article-title":"Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum beta-lactamase producing gram-negative bacteria","volume":"46","author":"Fong","year":"2012","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.medcli.2017.07.023_bib0075","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.eimc.2015.11.017","article-title":"[Prevalence and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia] Spanish","volume":"34","author":"Blanco","year":"2016","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.medcli.2017.07.023_bib0080","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.ijid.2011.09.019","article-title":"Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: A propensity score analysis","volume":"16","author":"Wu","year":"2012","journal-title":"Int J Infect Dis."},{"key":"10.1016\/j.medcli.2017.07.023_bib0085","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/jac\/dkt091","article-title":"Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: Collateral damage or positive effect on hospital ecology?","volume":"68","author":"Sousa","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.medcli.2017.07.023_bib0090","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: A systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.medcli.2017.07.023_bib0095","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajic.2014.06.013","article-title":"Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study","volume":"42","author":"Sorlozano","year":"2014","journal-title":"Am J Infect Control."},{"key":"10.1016\/j.medcli.2017.07.023_bib0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2334-12-245","article-title":"Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study","volume":"12","author":"Peralta","year":"2012","journal-title":"BMC Infect Dis."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317306516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317306516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T18:26:52Z","timestamp":1530642412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317306516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0025775317306516"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.07.023","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Escherichia coli y Klebsiella pneumoniae productores de betalactamasa de espectro extendido en infecciones de v\u00edas urinarias: evoluci\u00f3n de la resistencia antibi\u00f3tica y opciones terap\u00e9uticas","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}